Sai Life Sciences Limited (SAILIFE) — Announcement | 4 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company announces analyst/investor meeting schedule
💡 Investor Takeaway
Investors should note the meeting dates may shift and no new price sensitive details will be shared.

Sai Life Sciences announced a schedule of analyst and investor meetings on August 13 and 14, 2026, in Singapore, organized by Avendus Spark INDX-Asia Edition 2026, with a note that the schedule may change and no unpublished price sensitive information will be discussed.

📄 View Original Announcement (PDF)

About Sai Life Sciences Limited (SAILIFE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹30,970.41 Cr P/E: 85.0 ROE: 14.6% ROCE: 20.1%

View full SAILIFE stock details →

📡 Get AI alerts when SAILIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAILIFE — Free

📊 More SAILIFE filings

See all SAILIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SAILIFE files new disclosures

Track SAILIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAILIFE — Free

Free account · 2 AI queries/day